BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32814324)

  • 21. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
    Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic significance of endocervical glandular cells with "golden-yellow" mucin on pap smear.
    Hata S; Mikami Y; Manabe T
    Diagn Cytopathol; 2002 Aug; 27(2):80-4. PubMed ID: 12203873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.
    Liao SY; Rodgers WH; Kauderer J; Darcy KM; Carter R; Susumu N; Nagao S; Walker JL; Hatae M; Stanbridge EJ
    Br J Cancer; 2013 Feb; 108(3):613-20. PubMed ID: 23299542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
    Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tall-columnar glandular cells in SurePath™ liquid-based cytology Pap sample: Learning from mimics/pitfalls.
    Gupta N; Jain V; Srinivasan R; Singh T
    Cytopathology; 2024 Jul; 35(4):510-514. PubMed ID: 38712698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
    Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
    Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The developing spectrum of gastric-type cervical glandular lesions.
    Talia KL; McCluggage WG
    Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra.
    Takeuchi K; Tsujino T; Sugimoto M; Yoshida S; Kitazawa S
    Int J Gynecol Cancer; 2008; 18(6):1285-8. PubMed ID: 18217972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia.
    Ota H; Harada O; Uehara T; Hayama M; Ishii K
    Am J Clin Pathol; 2011 Feb; 135(2):253-61. PubMed ID: 21228366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful pregnancy in a Peutz-Jeghers syndrome patient with lobular endocervical glandular hyperplasia.
    Takei Y; Fujiwara H; Nagashima T; Takahashi Y; Takahashi S; Suzuki M
    J Obstet Gynaecol Res; 2015 Mar; 41(3):468-73. PubMed ID: 25257303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
    Kimura F; Kobayashi T; Kanai R; Kobayashi Y; Yuhi O; Ota H; Yamaguchi M; Yokokawa Y; Uehara T; Ishii K
    Diagn Cytopathol; 2019 Jun; 47(6):553-563. PubMed ID: 30761780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
    Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
    Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited frequency of malignant change in lobular endocervical glandular hyperplasia.
    Kobara H; Miyamoto T; Ando H; Asaka R; Takatsu A; Ohya A; Asaka S; Shiozawa T
    Int J Gynecol Cancer; 2020 Oct; 30(10):1480-1487. PubMed ID: 32883699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adenoma malignum and lobular endocervical glandular hyperplasia (LEGH)].
    Shiozawa T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():114-21. PubMed ID: 23156228
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.
    Ando H; Miyamoto T; Kashima H; Takatsu A; Ishii K; Fujinaga Y; Shiozawa T
    J Obstet Gynaecol Res; 2016 Nov; 42(11):1588-1598. PubMed ID: 27718288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.
    Ohta Y; Suzuki T; Hamatani S; Shiokawa A; Kushima M; Ota H
    Pathol Res Pract; 2008; 204(9):683-7. PubMed ID: 18462891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
    Gordhandas SB; Kahn R; Sassine D; Aviki EM; Baltich Nelson B; Catchings A; Liu YL; Lakhman Y; Abu-Rustum NR; Park KJ; Mueller JJ
    Int J Gynecol Cancer; 2022 Jan; 32(1):79-88. PubMed ID: 34903560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
    Mikami Y; McCluggage WG
    Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
    Mikami Y; Kiyokawa T; Moriya T; Sasano H
    Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.